Biomarkers for sepsis: past, present and future

Main Article Content

Giuseppe Chesi *
Natale Vazzana
Claudio Giumelli
(*) Corresponding Author:
Giuseppe Chesi | chesig@ausl.re.it

Abstract

Sepsis is a complication of severe infection associated with high mortality and open diagnostic issues. Treatment strategies are currently limited and essentially based on prompt recognition, aggressive supportive care and early antibiotic treatment. In the last years, extensive antibiotic use has led to selection, propagation and maintenance of drug-resistant microorganisms. In this context, several biomarkers have been proposed for early identification, etiological definition, risk stratification and improving antibiotic stewardship in septic patient care. Among these molecules, only a few have been translated into clinical practice. In this review, we provided an updated overview of established and developing biomarkers for sepsis, focusing our attention on their pathophysiological profile, advantages, limitations, and appropriate evidence-based use in the management of septic patients.

Downloads month by month

Downloads

Download data is not yet available.

Article Details